IPSENCONSUMERHEALTHCARE目前是博福--益普生(天津)制药有限公司直接控股股东,持股比例为96%;目前IPSENCONSUMERHEALTHCARE是5家企业最终受益人,包括其在投资博福-益普生(天津)制药有限公司成都分公司最终收益股份为96%,投资博福--益普生(天津)制药有限公司最终收益股份为96%等;二、IPSENCONSUMERHEALTHCARE的商业合作伙伴...
L. Marie started her career more than 20 years ago helping others access community health programs and healthcare—a skillset she never imagined would eventually be put to use advocating for her own health after being dismissed by her doctors. IPN price €94.15 €2.10 (2.28%) Media Inves...
Ipsen appoints Keira Driansky as EVP, President of North America Oncology –13 February 2024 Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by… Rare Diseases –14 November 2023 Results from Ipsen’s ELATIVE® p...
爱企查为您提供IPSENCONSUMERHEALTHCAREC2023年企业商标信息查询,包括企业商标注册信息、商标logo,商标类别等企业商标信息查询,让您更轻松的了解IPSENCONSUMERHEALTHCAREC商标信息,查询更多关于IPSENCONSUMERHEALTHCAREC商标信息就到爱企查官网!
IPSEN CONSUMER HEALTHCARE于2008年04月01日申请了名称为SMECTA的第5类商标,商标注册号为G953363,由国际局代理申请。
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society.
天眼查为您提供IPSEN CONSUMER HEALTHCARE商标信息查询,包括企业商标注册信息、商标logo、商标类别、注册号等商标信息,让您能够快速了解IPSEN CONSUMER HEALTHCARE商标信息,想要查询更多关于IPSEN CONSUMER HEALTHCARE的相关公司信息,就上天眼查!
NVIDIA CORPORATION -2.87% WORKDAY INC. -2.94% Created with Highcharts 9.3.3TechnologyTechnology Consume… Consume… Bas… Bas…HealthcareHealthcare Consumer No… Consumer No… Industria… Industria… Uti… Uti…
Completion of the divestment of Ipsen’s Consumer HealthCare business (CHC) to Mayoly Spindler Submission acceptance by U.S. FDA for New Drug Application (NDA) for palovaroteneUpgraded 2022 financial guidanceTotal-sales growth greater than 7.0% at CER1 (prior guidance: >2.0%) Core ...
About Ipsen. Ipsen is a global, mid-sized biopharmaceutical company focused on transformative medicines in Oncology,Rare Diseaseand Neuroscience; it also has a well-establishedConsumer Healthcare business. WithTotal Salesof over €2.5bn inFY 2020, Ipsen sells more than 20 medicines in over 115 count...